For cancer-derived EVs, epithelial cell surface molecules including EPCAM were effective markers of pancreatic cancer [30], while endothelial cell-derived EVs with CD31 and CD146 represented atherosclerotic disease markers [31]. This evidence concerns the gene EPCAM and familial pancreatic carcinoma.